In response to COVID-19, GHX is committed to helping ensure that our customers receive access to the data and information needed to help maintain critical supplies to serve patients and protect staff. Click to learn more
Log In

In October 2018, the Center for Medicare & Medicaid Services dramatically reduced reimbursement for peripheral venoarterial and venovenous extracorporeal membrane oxygenation (ECMO), which has led hospitals to reexamine ECMO selection and discontinuation criteria for patients with cardiac or respiratory failure.

Download this PDF to read why can be a valuable tool but should only be used after considering appropriate patient selection, duration and discontinuation.

“Evidence Insight Spotlight: Extracorporeal Membrane Oxygenation (ECMO)”

Download Now